Tumor mutational burden (TMB) and response rates to immune checkpoint inhibitors (ICIs) targeting PD-1, CTLA-4, and combination.

被引：5
作者：
Osipov, Arsen
Popovic, Aleksandra
Hopkins, Alexander
Frampton, Garrett M.
Albacker, Lee A.
Azad, Nilofer Saba
Laheru, Daniel A.
Zheng, Lei
Jaffee, Elizabeth M.
Yarchoan, Mark
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Balimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[6] Johns Hopkins Univ Hosp, Baltimore, MD USA
[7] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.2578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2578
引用
收藏
页数：1
相关论文
共 50 条
[21]   Combination of CTLA-4 and PD-1 blockers for treatment of cancer [J].
Rotte, Anand .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
[22]   Combination of CTLA-4 and PD-1 blockers for treatment of cancer [J].
Anand Rotte .
Journal of Experimental & Clinical Cancer Research, 38
[23]   Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4 [J].
Guo, Jing ;
Xue, Zhonghui ;
Wang, Lie .
CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (07) :861-862
[24]   Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis [J].
Jin, Chunhui ;
Zhu, Xiaodan ;
Huang, Xiaona ;
Gong, Tingjie ;
Wei, Zhipeng ;
You, Jianliang .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (03) :203-212
[25]   Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4 [J].
Jing Guo ;
Zhonghui Xue ;
Lie Wang .
Cellular & Molecular Immunology, 2022, 19 :861-862
[26]   The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma [J].
Wang, Sheng-Dong ;
Li, Heng-Yuan ;
Li, Bing-Hao ;
Xie, Tao ;
Zhu, Ting ;
Sun, Ling-Ling ;
Ren, Hai-Yong ;
Ye, Zhao-Ming .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 38 :81-89
[27]   Tumor mutational burden as a marker for radiologic response to immune checkpoint inhibitors [J].
Futela, Dheeman ;
Tirumani, Sree Harsha ;
Guler, Ezgi ;
Declouette, Brandon ;
Hoimes, Christopher ;
Ramaiya, Nikhil H. .
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2025, 54 (04) :460-464
[28]   Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 [J].
Romain-David Seban ;
Antoine Moya-Plana ;
Lara Antonios ;
Randy Yeh ;
Aurélien Marabelle ;
Eric Deutsch ;
Lawrence H. Schwartz ;
Ruth Gabriela Herrera Gómez ;
Yvonne Saenger ;
Caroline Robert ;
Samy Ammari ;
Laurent Dercle .
European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 :2301-2312
[29]   Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 [J].
Seban, Romain-David ;
Moya-Plana, Antoine ;
Antonios, Lara ;
Yeh, Randy ;
Marabelle, Aurelien ;
Deutsch, Eric ;
Schwartz, Lawrence H. ;
Gomez, Ruth Gabriela Herrera ;
Saenger, Yvonne ;
Robert, Caroline ;
Ammari, Samy ;
Dercle, Laurent .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (10) :2301-2312
[30]   Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition [J].
Sun, Michel M. ;
Levinson, Ralph D. ;
Filipowicz, Artur ;
Anesi, Stephen ;
Kaplan, Henry J. ;
Wang, Wei ;
Goldstein, Debra A. ;
Gangaputra, Sapna ;
Swan, Robert T. ;
Sen, H. Nida ;
Gordon, Lynn K. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (02) :217-227
12345